Early appraisal of China's huge and complex health-care reforms
- PMID: 22386036
- DOI: 10.1016/S0140-6736(11)61880-1
Early appraisal of China's huge and complex health-care reforms
Abstract
China's 3 year, CN¥850 billion (US$125 billion) reform plan, launched in 2009, marked the first phase towards achieving comprehensive universal health coverage by 2020. The government's undertaking of systemic reform and its affirmation of its role in financing health care together with priorities for prevention, primary care, and redistribution of finance and human resources to poor regions are positive developments. Accomplishing nearly universal insurance coverage in such a short time is commendable. However, transformation of money and insurance coverage into cost-effective services is difficult when delivery of health care is hindered by waste, inefficiencies, poor quality of services, and scarcity and maldistribution of the qualified workforce. China must reform its incentive structures for providers, improve governance of public hospitals, and institute a stronger regulatory system, but these changes have been slowed by opposition from stakeholders and lack of implementation capacity. The pace of reform should be moderated to allow service providers to develop absorptive capacity. Independent, outcome-based monitoring and evaluation by a third-party are essential for mid-course correction of the plans and to make officials and providers accountable.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Comment in
-
What can be learned from China's health system?Lancet. 2012 Mar 3;379(9818):777. doi: 10.1016/S0140-6736(12)60327-4. Lancet. 2012. PMID: 22386010 No abstract available.
-
Tuberculosis control in China: striving for sustainability.Lancet. 2012 Jun 9;379(9832):2149. doi: 10.1016/S0140-6736(12)60942-8. Lancet. 2012. PMID: 22682462 No abstract available.
Similar articles
-
China's health care system reform: Progress and prospects.Int J Health Plann Manage. 2017 Jul;32(3):240-253. doi: 10.1002/hpm.2424. Epub 2017 Jun 14. Int J Health Plann Manage. 2017. PMID: 28612498
-
From a national, centrally planned health system to a system based on the market: lessons from China.Health Aff (Millwood). 2008 Jul-Aug;27(4):937-48. doi: 10.1377/hlthaff.27.4.937. Health Aff (Millwood). 2008. PMID: 18607026
-
A pilot project using evidence-based clinical pathways and payment reform in China's rural hospitals shows early success.Health Aff (Millwood). 2013 May;32(5):963-73. doi: 10.1377/hlthaff.2012.0640. Epub 2013 Apr 3. Health Aff (Millwood). 2013. PMID: 23552049
-
Harnessing the privatisation of China's fragmented health-care delivery.Lancet. 2014 Aug 30;384(9945):805-18. doi: 10.1016/S0140-6736(14)61120-X. Lancet. 2014. PMID: 25176551 Free PMC article. Review.
-
China's Health Reform Update.Annu Rev Public Health. 2017 Mar 20;38:431-448. doi: 10.1146/annurev-publhealth-031816-044247. Epub 2017 Jan 11. Annu Rev Public Health. 2017. PMID: 28125384 Review.
Cited by
-
Association of professional identity, job satisfaction and burnout with turnover intention among general practitioners in China: evidence from a national survey.BMC Health Serv Res. 2021 Apr 26;21(1):382. doi: 10.1186/s12913-021-06322-6. BMC Health Serv Res. 2021. PMID: 33902579 Free PMC article.
-
Inequity in level of healthcare utilization before and after universal health coverage reforms in China: evidence from household surveys in Sichuan Province.Int J Equity Health. 2016 Jun 22;15:96. doi: 10.1186/s12939-016-0385-x. Int J Equity Health. 2016. PMID: 27334384 Free PMC article.
-
Financial protection effects of private health insurance: experimental evidence from Chinese households with resident basic medical insurance.Int J Equity Health. 2021 May 17;20(1):122. doi: 10.1186/s12939-021-01468-5. Int J Equity Health. 2021. PMID: 34001149 Free PMC article.
-
Geographic Variation in Process and Outcomes of Care for Patients With Acute Myocardial Infarction in China From 2001 to 2015.JAMA Netw Open. 2020 Oct 1;3(10):e2021182. doi: 10.1001/jamanetworkopen.2020.21182. JAMA Netw Open. 2020. PMID: 33095248 Free PMC article.
-
Cost-utility analysis of the newly recommended adjuvant chemotherapy for resectable gastric cancer patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer.Pharmacoeconomics. 2014 Mar;32(3):235-43. doi: 10.1007/s40273-013-0065-2. Pharmacoeconomics. 2014. PMID: 23709451
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical